Call Options

28 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $6.47 Million - $7.05 Million
20,900 Added 13.55%
175,100 $56.4 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $7.59 Million - $9.23 Million
-28,900 Reduced 15.78%
154,200 $48.2 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $21.5 Million - $26 Million
80,100 Added 77.77%
183,100 $52.1 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $11.5 Million - $13 Million
-45,000 Reduced 30.41%
103,000 $29.7 Million
Q3 2023

Nov 15, 2023

SELL
$218.65 - $271.46 $2.93 Million - $3.64 Million
-13,400 Reduced 8.3%
148,000 $39.8 Million
Q2 2023

Aug 23, 2023

SELL
$214.27 - $253.37 $12.2 Million - $14.5 Million
-57,100 Reduced 26.13%
161,400 $35.8 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $23.5 Million - $28.7 Million
104,200 Added 91.16%
218,500 $52.8 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $45,806 - $58,202
200 Added 0.18%
114,300 $30 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $8.89 Million - $10 Million
39,600 Added 53.15%
114,100 $26.1 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $6.3 Million - $7.01 Million
-27,300 Reduced 26.82%
74,500 $18.3 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $22.3 Million - $24.7 Million
101,800 New
101,800 $24.7 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $19.1 Million - $21.8 Million
-96,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $20.4 Million - $23.9 Million
96,000 New
96,000 $20.6 Million
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $16.9 Million - $18.7 Million
-72,200 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $621,348 - $724,080
2,800 Added 4.03%
72,200 $18 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $4.31 Million - $5.13 Million
-19,900 Reduced 22.28%
69,400 $15.8 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $2.23 Million - $2.48 Million
-9,500 Reduced 9.62%
89,300 $22.2 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $17.2 Million - $21.2 Million
-87,200 Reduced 46.88%
98,800 $22.9 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $1.09 Million - $1.45 Million
-6,000 Reduced 3.13%
186,000 $38.8 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $15.8 Million - $20.3 Million
83,500 Added 76.96%
192,000 $46.1 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $4.98 Million - $5.97 Million
-28,600 Reduced 20.86%
108,500 $21.2 Million
Q2 2019

Aug 20, 2019

BUY
$166.7 - $195.41 $22.9 Million - $26.8 Million
137,100 New
137,100 $25.3 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $27.9 Million - $31.5 Million
-154,400 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $3.43 Million - $4 Million
19,200 Added 14.2%
154,400 $29.4 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $13.8 Million - $15.6 Million
-74,700 Reduced 35.59%
135,200 $28 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $35.6 Million - $41.6 Million
209,900 New
209,900 $35.8 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $30.7 Million - $34.3 Million
-182,100 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $30.5 Million - $34.8 Million
182,100
182,100 $34 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.